Impact Corelab has announced the appointment of two new members to its board of directors, both from affiliated company Radiological Associates of Sacramento (RAS), with key specialties and sub-specialties relevant to the company's focus areas. Dr. Vipin Bansal, M.D., currently Chair of the RAS Finance Committee, and Dr. Mark Leibenhaut, M.D., F.A.C.R., an Executive Committee member for RAS, have both joined the Impact Corelab board, effective immediately.
Impact Corelab combines cloud-based data on demand with experienced doctors, project managers, and clinicians to deliver guaranteed transparency, reliability, and query reduction for sponsors and CROs in image-based trials. The company's services enable rapid trial starts, minimal capital investment, and better control over real-time data, backed up by resources that include 1,000 doctors, radiology specialists, and project managers in a radiology practice that is nearly a century old.
"We are delighted to welcome Dr. Bansal and Dr. Leibenhaut to our board," said Dr. Benjamin Franc M.D., M.S., acting CEO and Chairman of the Board. "They have been deeply involved in the RAS practice for several years, and both add a depth of business, radiological, and therapeutic insights to help guide Impact Corelab as we move to capitalize on the market's unmet needs for improved transparency and control over image-based trials."
